Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 2.46
7.89 %
$ 78.9 M
Market Cap
-2.02
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
20.96%
EBIT
Estimate
--23.85%
Net Income
Estimate
83.12%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Neuronetics, Inc.
STIM has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart STIM
EBIT FORECAST
EBIT Forecast Chart STIM
NET INCOME FORECAST
Net Income Chart STIM